Compile Data Set for Download or QSAR
maximum 50k data
Found 110 of ic50 for UniProtKB: P07949
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296812(6-ethoxy-4-(5-(6-(3- fluoro-4- methoxybenzyl)-3,6-...)
Affinity DataIC50:  39nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296735(US10112942, Example 470 | US10137124, Example 470 ...)
Affinity DataIC50:  41nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296716(US10112942, Example 451 | US10137124, Example 451 ...)
Affinity DataIC50:  52.4nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296381(US10112942, Example 115 | US10137124, Example 115 ...)
Affinity DataIC50:  54.3nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM430529(US10555944, Example 261 | US10953005, Example 261)
Affinity DataIC50:  58.7nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296809(US10112942, Example 544 | US10137124, Example 544 ...)
Affinity DataIC50:  65nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296709(US10112942, Example 444 | US10137124, Example 444 ...)
Affinity DataIC50:  68.5nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296772(US10112942, Example 507 | US10137124, Example 507 ...)
Affinity DataIC50:  79nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296521(US10112942, Example 255 | US10137124, Example 255 ...)
Affinity DataIC50:  80.1nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296727(US10112942, Example 462 | US10137124, Example 462 ...)
Affinity DataIC50:  84.8nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296376(US10112942, Example 110 | US10137124, Example 110 ...)
Affinity DataIC50:  90nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296707(US10112942, Example 442 | US10137124, Example 442 ...)
Affinity DataIC50:  101nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296817(US10112942, Example 552 | US10137124, Example 552 ...)
Affinity DataIC50:  101nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296808(US10112942, Example 543 | US10112942, Example 546 ...)
Affinity DataIC50:  102nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296520(US10112942, Example 254 | US10137124, Example 254 ...)
Affinity DataIC50:  104nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296703(US10112942, Example 438 | US10137124, Example 438 ...)
Affinity DataIC50:  105nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296715(US10112942, Example 450 | US10137124, Example 450 ...)
Affinity DataIC50:  113nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296711(US10112942, Example 446 | US10137124, Example 446 ...)
Affinity DataIC50:  120nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296724(US10112942, Example 459 | US10137124, Example 459 ...)
Affinity DataIC50:  123nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296704(US10112942, Example 439 | US10137124, Example 439 ...)
Affinity DataIC50:  128nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296773(US10112942, Example 508 | US10137124, Example 508 ...)
Affinity DataIC50:  143nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296774(US10112942, Example 509 | US10137124, Example 509 ...)
Affinity DataIC50:  147nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296821(US10112942, Example 556 | US10137124, Example 556 ...)
Affinity DataIC50:  153nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296818(US10112942, Example 553 | US10137124, Example 553 ...)
Affinity DataIC50:  153nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296748(US10112942, Example 483 | US10137124, Example 483 ...)
Affinity DataIC50:  159nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296736(US10112942, Example 471 | US10137124, Example 471 ...)
Affinity DataIC50:  175nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296241(US10112942, Example 48 | US10137124, Example 48 | ...)
Affinity DataIC50:  182nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296775(6-ethoxy-4-(6-(1-((4- fluorophenyl) sulfonyl)-1,6-...)
Affinity DataIC50:  192nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296195(US10112942, Example 2 | US10137124, Example 2 | US...)
Affinity DataIC50:  202nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296743(US10112942, Example 478 | US10137124, Example 478 ...)
Affinity DataIC50:  208nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296725(US10112942, Example 460 | US10137124, Example 460 ...)
Affinity DataIC50:  208nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296712(US10112942, Example 447 | US10137124, Example 447 ...)
Affinity DataIC50:  213nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296807(US10112942, Example 542 | US10137124, Example 542 ...)
Affinity DataIC50:  229nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296744(US10112942, Example 479 | US10137124, Example 479 ...)
Affinity DataIC50:  242nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296698(US10112942, Example 433 | US10137124, Example 433 ...)
Affinity DataIC50:  247nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296740(US10112942, Example 475 | US10137124, Example 475 ...)
Affinity DataIC50:  252nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296214(US10112942, Example 21 | US10137124, Example 21 | ...)
Affinity DataIC50:  255nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296702(US10112942, Example 437 | US10137124, Example 437 ...)
Affinity DataIC50:  278nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296717(US10112942, Example 452 | US10137124, Example 452 ...)
Affinity DataIC50:  282nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM303768(6-ethoxy-4-(5-(6-((6- ethylpyridin-3- yl)methyl)-3...)
Affinity DataIC50:  284nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296824(6-ethoxy-4-(5-(6-((6- methoxy-5- methylpyridin-3- ...)
Affinity DataIC50:  302nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296816(US10112942, Example 551 | US10137124, Example 551 ...)
Affinity DataIC50:  323nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296701(US10112942, Example 436 | US10137124, Example 436 ...)
Affinity DataIC50:  351nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296813(6-ethoxy-4-(5-(6-((5- methoxypyridin-2- yl)methyl)...)
Affinity DataIC50:  374nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296777(6-ethoxy-4-(6-(1-((4- methoxyphenyl) sulfonyl)-1,6...)
Affinity DataIC50:  380nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296402(US10112942, Example 136 | US10137124, Example 136 ...)
Affinity DataIC50:  387nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296714(US10112942, Example 449 | US10137124, Example 449 ...)
Affinity DataIC50:  401nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296815(US10112942, Example 550 | US10137124, Example 550 ...)
Affinity DataIC50:  433nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM296788(US10112942, Example 523 | US10137124, Example 523 ...)
Affinity DataIC50:  473nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly

US Patent
LigandPNGBDBM303406(US10137124, Example 183 | US10172851, Example 183 ...)
Affinity DataIC50:  473nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 110 total ) | Next | Last >>
Jump to: